Safety, Effectiveness and Patient Acceptance of the Treatment With MabCampath in Chronic Lymphocytic Leukemia

Clinical trial NCT00836043 · TERMINATED

Trial details

NCT number: NCT00836043
Sponsor: Genzyme, a Sanofi Company
Status: TERMINATED
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2008-10-01
Primary completion: 2009-04-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.